May 2010 - FRMC

Department

News Connection

05/24/2010

The US Food and Drug Administration (FDA) has approved Natazia, a combination hormonal tablet for use as an oral contraceptive. Natazia contains two female hormones, an estrogen (estradiol valerate) and a progestin (dienogest), and is the...

The US Food and Drug...

05/24/2010

First Report Managed Care

Conference Insider

Value-Based Designs Are a Solid Investment Even in a Slow Economy

05/24/2010

Jill Sederstorm ;

Value-based design insurance programs have remained a viable investment strategy even during the latest economic downturn, according to the results of a recent survey.

Value-based design insurance...

05/24/2010

First Report Managed Care

News Connection

Health Disparities Collaboratives Have Minimal Effect on Racial/Ethnic and Insurance Disparities in US Community Health Centers

05/24/2010

Tim Casey ;

In a recent controlled preintervention/postintervention study, researchers found that although Health Resources and Services Administration (HRSA) Health Disparities Collaboratives (HDCs) are known to improve quality of care in community...

In a recent controlled...

05/24/2010

First Report Managed Care

News Connection

Counting Their Medical Losses

05/21/2010

Charles Boersig ;

Health insurers are considering the financial impact of mandatory medical loss ratios (MLRs) requiring them to spend minimum percentages of the premiums they collect on providing healthcare to customers.

Health insurers are considering...

05/21/2010

First Report Managed Care

News Connection

Reimbursement Runaround Redux

05/21/2010

Charles Boersig ;

Temporarily delaying mandated reimbursement cuts for physicians providing Medicare services has become a routine and recurring event in the US Congress.

Temporarily delaying mandated...

05/21/2010

First Report Managed Care

Feature

Actemra (tocilizumab)

05/24/2010

Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor inhibitor used to treat adults with moderate-to-severe rheumatoid arthritis (RA).

Actemra (tocilizumab) is an...

05/24/2010

First Report Managed Care

Feature

Cost-Effectiveness of Chemotherapeutic Agents for Colorectal Cancer in a Medicare Population

05/24/2010

Tori Socha ;

Bevacizumab and cetuximab, have been singled out as examples of high-cost/low-value medical care. Previously, bevacizumab has been shown to extend median survival time by 3 to 5 months at a cost that can exceed $8000 per month.

Bevacizumab and cetuximab, have...

05/24/2010

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

New Approach Shows Promise for Treating Advanced Stage Ovarian Cancer in Lab

11/28/2014

A recombinant version of thrombospondin-1 type I repeats (3TSR) in combination with chemotherapy shows promise in a mouse model of advanced stage epithelial ovarian cancer.

A recombinant version of...

11/28/2014

First Report Managed Care

News

Cost of Autologous Stem Cell Transplant for Multiple Myeloma Decreasing

12/06/2017

Research presented at ASH 2017 will highlight how costs for autologous stem cell transplantation have decreased over the past decade.

Research presented at ASH 2017...

12/06/2017

First Report Managed Care

COPD Projected to be Third Leading Cause of Death by 2020

11/14/2014

Kerri Fitzgerald ;

Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide, and by 2020, COPD will be the third leading cause of mortality.

Chronic obstructive pulmonary...

11/14/2014

First Report Managed Care

News

Debt-limit deal triggers lobbying campaign from health-care and defense industries

08/04/2011

First Report Managed Care

News

Walgreens: no new Medicaid patients as of April 16

03/18/2010

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton , MD;

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

May 2010 - FRMC

Department

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

May 2010 Volume 7 Issue 5

Specialties

Events

Year Round Education

HMP Global Products